Loading...
Ipsen S.A.
IPSEF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$117.60
$4.47(3.95%)
Ipsen S.A. (IPSEF) Financial Performance & Income Statement Overview
Review Ipsen S.A.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
8.11%
↑ 8.11%
Operating Income Growth
-39.13%
↓ 39.13%
Net Income Growth
-46.32%
↓ 46.32%
Operating Cash Flow Growth
5.73%
↑ 5.73%
Operating Margin
25.52%
↑ 25.52%
Gross Margin
81.37%
↑ 81.37%
Net Profit Margin
22.91%
↑ 22.91%
ROE
14.36%
↑ 14.36%
ROIC
12.90%
↑ 12.90%
Ipsen S.A. (IPSEF) Income Statement & Financial Overview
Review Ipsen S.A.'s (IPSEF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $1.82B | $1.75B | $1.59B | $1.54B |
| Cost of Revenue | $302.00M | $316.70M | $301.30M | $269.90M |
| Gross Profit | $1.52B | $1.44B | $1.29B | $1.27B |
| Gross Profit Ratio | $0.83 | $0.82 | $0.81 | $0.82 |
| R&D Expenses | $363.20M | $323.40M | $329.10M | $290.20M |
| SG&A Expenses | $599.30M | $574.90M | $582.20M | $552.70M |
| Operating Expenses | $1.34B | $1.12B | $818.90M | $756.40M |
| Total Costs & Expenses | $1.64B | $1.43B | $1.12B | $1.03B |
| Interest Income | $0.00 | $5.60M | $3.80M | $3.00M |
| Interest Expense | $0.00 | $10.90M | $11.20M | $15.00M |
| Depreciation & Amortization | $191.10M | $160.70M | $160.60M | $155.60M |
| EBITDA | $709.80M | $481.70M | $631.30M | $240.10M |
| EBITDA Ratio | $0.39 | $0.27 | $0.40 | $0.43 |
| Operating Income | $178.90M | $317.80M | $470.70M | $510.30M |
| Operating Income Ratio | $0.10 | $0.18 | $0.30 | $0.33 |
| Other Income/Expenses (Net) | -$36.20M | -$28.30M | $29.40M | -$384.75M |
| Income Before Tax | $142.70M | $289.50M | $500.10M | $261.40M |
| Income Before Tax Ratio | $0.08 | $0.17 | $0.31 | $0.17 |
| Income Tax Expense | $27.70M | $47.20M | $80.20M | $56.00M |
| Net Income | $113.90M | $232.00M | $449.20M | $195.20M |
| Net Income Ratio | $0.06 | $0.13 | $0.28 | $0.13 |
| EPS | $1.37 | $2.90 | $5.44 | $2.36 |
| Diluted EPS | $1.37 | $2.78 | $5.38 | $2.35 |
| Weighted Avg Shares Outstanding | $83.20M | $80.005M | $82.64M | $82.64M |
| Weighted Avg Shares Outstanding (Diluted) | $83.33M | $83.45M | $83.51M | $83.06M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan